Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stockholders' Deficit - Stock Options (Details)

v3.19.2
Note 6 - Stockholders' Deficit - Stock Options (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Outstanding, Number of Shares (in shares) 2,235,000  
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 1.74  
Outstanding, Weighted Average Remaining Life (Year) 9 years 40 days 9 years 160 days
Outstanding, Aggregate Intrinsic Value $ 34,496,387 $ 23,100
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 589,550  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.32  
Exercised, Number of Shares (in shares)  
Exercised, Weighted Average Exercise Price (in dollars per share)  
Cancelled, Number of Shares (in shares)  
Cancelled, Weighted Average Exercise Price (in dollars per share)  
Outstanding, Number of Shares (in shares) 2,824,550 2,235,000
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 2.49 $ 1.74
Exercisable, Number of Shares (in shares) 662,938  
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 1.73  
Exercisable, Weighted Average Remaining Life (Year) 8 years 94 days  
Exercisable, Aggregate Intrinsic Value $ 8,597,191